Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Frontiers in Medicine|December 23, 2022
The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapyLuca Castagna, Roberto Bono, Stefania Tringali, et al.
European Journal of Haematology|February 3, 2006
Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*Alessia Pepe, Massimo Lombardi, Vincenzo Positano, et al.
Blood Cells, Molecules & Diseases|March 1, 2011
The genetic heterogeneity of β-globin gene defects in Sicily reflects the historic population migrations of the islandAntonino Giambona, Margherita Vinciguerra, Monica Cannata, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 9, 2009
The sea urchin sns5 insulator protects retroviral vectors from chromosomal position effects by maintaining active chromatin structureDanilo D'Apolito, Elena Baiamonte, Mariella Bagliesi, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 29, 2006
Multislice multiecho T2* cardiovascular magnetic resonance for detection of the heterogeneous distribution of myocardial iron overloadAlessia Pepe, Vincenzo Positano, Maria Filomena Santarelli, et al.
Haematologica|September 12, 2006
Risk factors for death in patients with beta-thalassemia major: results of a case-control studyAdriana Ceci, Paola Baiardi, Mariana Catapano, et al.
The American Journal of Gastroenterology|March 18, 2008
The role of CARD15 mutations and smoking in the course of Crohn's disease in a Mediterranean areaMaria Concetta Renda, Ambrogio Orlando, Giuseppe Civitavecchia, et al.
Hemoglobin|August 29, 2019
Double Heterozygosity for Hb Durham-N.C. (<i>HBB</i>: c.344T>C) [β114(G16)Leu→Pro] and the IVS-I-110 (<i>HBB</i>: c.93-21G>A) Causing a Severe β-Thalassemia PhenotypeMonica Cannata, Filippo Cassarà, Margherita Vinciguerra, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 12, 2008
Guideline recommendations for heart complications in thalassemia majorTiziana Cogliandro, Giorgio Derchi, Luigi Mancuso, et al.
Blood Cells, Molecules & Diseases|May 13, 2014
Deferiprone versus deferoxamine in sickle cell disease: results from a 5-year long-term Italian multi-center randomized clinical trialGiusi Calvaruso, Angela Vitrano, Rosario Di Maggio, et al.
Pageof 13